North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Sunitinib
found
7 matches
Open monograph to display formulary status
BNF Category
Sunitinib
(Sutent
®
)
Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
Links
Link to Drug Section
Link to document
MHRA Drug Safety Update (January 2011): Bevacizumab and sunitinib: risk of osteonecrosis of the jaw (08.01.05)
MHRA Drug Safety Update (January 2011): Bevacizumab and sunitinib: risk of osteonecrosis of the jaw (08.01.05)
NICE TA169: Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma (08.01.05)
NICE TA179: Sunitinib for the treatment of gastrointestinal stromal tumours (08.01.05)
NICE TA449 Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease (08.01.05)
NICE TA449 Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease (08.01.05)
